Literature DB >> 27340328

Secukinumab.

.   

Abstract

Keywords:  psoriasis; secukinumab

Year:  2015        PMID: 27340328      PMCID: PMC4917639          DOI: 10.18773/austprescr.2016.011

Source DB:  PubMed          Journal:  Aust Prescr        ISSN: 0312-8008


× No keyword cloud information.
  4 in total

1.  Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE).

Authors:  A Blauvelt; J C Prinz; A B Gottlieb; K Kingo; H Sofen; M Ruer-Mulard; V Singh; R Pathan; C Papavassilis; S Cooper
Journal:  Br J Dermatol       Date:  2014-12-11       Impact factor: 9.302

2.  Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial.

Authors:  Diamant Thaçi; Andrew Blauvelt; Kristian Reich; Tsen-Fang Tsai; Francisco Vanaclocha; Külli Kingo; Michael Ziv; Andreas Pinter; Sophie Hugot; Ruquan You; Marina Milutinovic
Journal:  J Am Acad Dermatol       Date:  2015-06-17       Impact factor: 11.527

3.  Secukinumab in plaque psoriasis--results of two phase 3 trials.

Authors:  Richard G Langley; Boni E Elewski; Mark Lebwohl; Kristian Reich; Christopher E M Griffiths; Kim Papp; Lluís Puig; Hidemi Nakagawa; Lynda Spelman; Bárður Sigurgeirsson; Enrique Rivas; Tsen-Fang Tsai; Norman Wasel; Stephen Tyring; Thomas Salko; Isabelle Hampele; Marianne Notter; Alexander Karpov; Silvia Helou; Charis Papavassilis
Journal:  N Engl J Med       Date:  2014-07-09       Impact factor: 91.245

4.  Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE).

Authors:  C Paul; J-P Lacour; L Tedremets; K Kreutzer; S Jazayeri; S Adams; C Guindon; R You; C Papavassilis
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-09-22       Impact factor: 6.166

  4 in total
  1 in total

Review 1.  Ixekizumab for psoriasis.

Authors: 
Journal:  Aust Prescr       Date:  2017-12-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.